Trace Biosciences
Beaverton
About Trace Biosciences
Trace Biosciences is working to make safe, precise surgery a reality by creating imaging agents that specifically highlight nerves for surgery. Our technology provides real-time visualization of buried, previously invisible nerves using near-infrared fluorescence that is compatible with clinical imaging systems and has application to every surgical specialty, so surgeons and surgical robots can cut by color, not by guesswork. With $9.3M raised ($8.1M in non-dilutive capital) and IND-enabling studies complete, we are ready to enter Phase I clinical trials in the coming months and are raising funding to complete Phase II trials, scale for broader clinical impact and commercial partnerships, and bring this transformative platform to every OR.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $8.4M
- Last round: Grant (Dec 2024)
- Website: trace-bio.com
- Phone: +1 971 202 0545
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Life Science, Medical
Social Profiles
Canonical: https://fsome.com/organization/trace-biosciences-91338 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.